Catechol-O-methyltransferase-mediated metabolism of 4-hydroxyestradiol inhibits the growth of human renal cancer cells through the apoptotic pathway

Carcinogenesis

Volumn 33, Issue 2, 2012, Pages 420-426

  Chang, Inik ^a   Liu, Jan ^a   Majid, Shahana ^a   Saini, Sharanjot ^a   Zaman, Mohd S ^a   Yamamura, Soichiro ^a   Shahryari, Varahram ^a   Chiyomaru, Takeshi ^a   Deng, Guoren ^a   Dahiya, Rajvir ^a   Tanaka, Yuichiro ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 HYDROXYESTRADIOL; 4 METHOXYESTRADIOL; CATECHOL METHYLTRANSFERASE; GROWTH ARREST AND DNA DAMAGE INDUCIBLE PROTEIN 45; GROWTH ARREST AND DNA DAMAGE INDUCIBLE PROTEIN 45 ALPHA; SMALL INTERFERING RNA; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER INHIBITION; CARCINOGENESIS; CELL CYCLE ARREST; CELL PROLIFERATION; CONTROLLED STUDY; DOWN REGULATION; ENZYME METABOLISM; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; KIDNEY CANCER; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; UPREGULATION;

EID: 84863034641     PISSN: 01433334     EISSN: 14602180     Source Type: Journal    
DOI: 10.1093/carcin/bgr294     Document Type: Article

References (38)

1. American Cancer Society. (2011) Cancer Facts & Figures. The Society, Atlanta, GA, p. 13.
2. Lipworth, L. et al. (2009) Epidemiologic characteristics and risk factors for renal cell cancer. Clin. Epidemiol., 1, 33-43.
3. Aron, M. et al. (2008) Impact of gender in renal cell carcinoma: an analysis of the SEER database. Eur. Urol., 54, 133-140.
4. Woldrich, J.M. et al. (2008) Sex differences in renal cell cancer presentation and survival: an analysis of the National Cancer Database, 1993-2004. J. Urol., 179, 1709-1713; discussion 1713.
5. Bjornerem, A. et al. (2007) Circulating sex steroids, sex hormone-binding globulin, and longitudinal changes in forearm bone mineral density in postmenopausalwomen and men: the Tromso study. Calcif. Tissue Int., 81, 65-72.
6. Thomas, T. et al. (2000) Relationship of serum leptin levels with body composition and sex steroid and insulin levels in men and women. Metabolism, 49, 1278-1284.
7. Bellet, R.E. et al. (1974) Estrogen-induced hypernephroma. J. Urol., 112, 160-161.
8. Nissenkorn, I. et al. (1979) Oestrogen-induced renal carcinoma. Br. J. Urol., 51, 6-9.
9. Lindblad, P. et al. (1995) International renal-cell cancer study. V. Reproductive factors, gynecologic operations and exogenous hormones. Int. J. Cancer, 61, 192-198.
10. Kirkman, H. et al. (1950) Malignant renal tumors in male hamsters (Cricetus auratus) treated with estrogen. Cancer Res., 10, 122-124.
11. Li, J.J. et al. (1980) Inhibition of estrogen tumorigenesis in the Syrian golden hamster kidney by antiestrogens. J. Natl Cancer Inst., 64, 795-800.
12. Zhu, B.T. et al. (1998) Functional role of estrogen metabolism in target cells: review and perspectives. Carcinogenesis, 19, 1-27.
13. Chen, Z.H. et al. (2005) 4-Hydroxyestradiol induces oxidative stress and apoptosis in human mammary epithelial cells: possible protection by NFkappaB and ERK/MAPK. Toxicol. Appl. Pharmacol., 208, 46-56.
14. Guldberg, H.C. et al. (1975) Catechol-O-methyl transferase: pharmacological aspects and physiological role. Pharmacol. Rev., 27, 135-206.
15. Cavalieri, E.L. et al. (1997) Molecular origin of cancer: catechol estrogen-3,4-quinones as endogenous tumor initiators. Proc. Natl Acad. Sci. USA, 94, 10937-10942.
16. Yager, J.D. et al. (1996) Molecular mechanisms of estrogen carcinogenesis. Annu. Rev. Pharmacol. Toxicol., 36, 203-232.
17. Sutherland, T.E. et al. (2007) 2-Methoxyestradiol-a unique blend of activities generating a new class of anti-tumour/anti-inflammatory agents. Drug Discov. Today, 12, 577-584.
18. Zhu, B.T. et al. (1994) Quercetin increases the severity of estradiol-induced tumorigenesis in hamster kidney. Toxicol. Appl. Pharmacol., 125, 149-158.
19. Zhu, B.T. et al. (1996) Inhibition of catechol O-methyltransferase-catalyzed O-methylation of 2- and 4-hydroxyestradiol by quercetin. Possible role in estradiol-induced tumorigenesis. J. Biol. Chem., 271, 1357-1363.
20. Salama, S.A. et al. (2008) Catecholestrogens induce oxidative stress and malignant transformation in human endometrial glandular cells: protective effect of catechol-O-methyltransferase. Int. J. Cancer, 123, 1246-1254.
21. Salama, S.A. et al. (2009) Catechol-o-methyltransferase expression and 2-methoxyestradiol affect microtubule dynamics and modify steroid receptor signaling in leiomyoma cells. PLoS One, 4, e7356.
22. Tanaka, Y. et al. (2007) Polymorphisms of catechol-O-methyltransferase in men with renal cell cancer. Cancer Epidemiol. Biomarkers Prev., 16, 92-97
23. Fisher, C. et al. (1994) Problems with p53 immunohistochemical staining: the effect of fixation and variation in the methods of evaluation. Br. J. Cancer, 69, 26-31.
24. Weisz, J. et al. (1998) Induction of nuclear catechol-O-methyltransferase by estrogens in hamster kidney: implications for estrogen-induced renal cancer. Carcinogenesis, 19, 1307-1312.
25. Tenhunen, J. et al. (1994) Genomic organization of the human catechol O-methyltransferase gene and its expression from two distinct promoters. Eur. J. Biochem., 223, 1049-1059.
26. Kato, S. et al. (2007) The oestrogen metabolite 2-methoxyoestradiol alone or in combination with tumour necrosis factor-related apoptosis-inducing ligand mediates apoptosis in cancerous but not healthy cells of the human endometrium. Endocr. Relat. Cancer, 14, 351-368.
27. Gong, Q.F. et al. (2011) 2ME and 2OHE2 exhibit growth inhibitory effects and cell cycle arrest at G2/M in RL95-2 human endometrial cancer cells through activation of p53 and Chk1. Mol. Cell. Biochem., 352, 221-230.
28. Meister, B. et al. (1993) Catechol-O-methyltransferase mRNA in the kidney and its appearance during ontogeny. Kidney Int., 44, 726-733.
29. Li, S.A. et al. (1989) Variations in catechol O-methyltransferase activity in rodent tissues: possible role in estrogen carcinogenicity. Carcinogenesis, 10, 63-67.
30. Xie, T. et al. (1999) Characterization and implications of estrogenic downregulation of human catechol-O-methyltransferase gene transcription. Mol. Pharmacol., 56, 31-38.
31. Jiang, H. et al. (2003) Human catechol-O-methyltransferase down-regulation by estradiol. Neuropharmacology, 45, 1011-1018.
32. Lachman, H.M. et al. (1996) Human catechol-O-methyltransferase pharmacogenetics: description of a functional polymorphism and its potential application to neuropsychiatric disorders. Pharmacogenetics, 6, 243-250.
33. Nackley, A.G. et al. (2006) Human catechol-O-methyltransferase haplotypes modulate protein expression by altering mRNA secondary structure. Science, 314, 1930-1933.
34. Baylin, S.B. et al. (2000) DNA hypermethylation in tumorigenesis: epigenetics joins genetics. Trends Genet., 16, 168-174.
35. Sasaki, M. et al. (2003) Multiple promoters of catechol-O-methyltransferase gene are selectively inactivated by CpG hypermethylation in endometrial cancer. Cancer Res., 63, 3101-3106.
36. Zhu, B.T. et al. (1996) Metabolic deglucuronidation and demethylation of estrogen conjugates as a source of parent estrogens and catecholestrogen metabolites in Syrian hamster kidney, a target organ of estrogen-induced tumorigenesis. Toxicol. Appl. Pharmacol., 136, 186-193.
37. Dawling, S. et al. (2003) Methoxyestrogens exert feedback inhibition on cytochrome P450 1A1 and 1B1. Cancer Res., 63, 3127-3132.
38. Cheng, Y. et al. (2007) 4-Methoxyestradiol-induced oxidative injuries in human lung epithelial cells. Toxicol. Appl. Pharmacol., 220, 271-277.